Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Effect of aliskiren on post-discharge outcomes among diabetic and non-diabetic patients hospitalized for heart failure: insights from the ASTRONAUT trial.

Maggioni AP, Greene SJ, Fonarow GC, Böhm M, Zannad F, Solomon SD, Lewis EF, Baschiera F, Hua TA, Gimpelewicz CR, Lesogor A, Gheorghiade M; ASTRONAUT Investigators and Coordinators..

Eur Heart J. 2013 Oct;34(40):3117-27. doi: 10.1093/eurheartj/eht342. Epub 2013 Sep 2.

2.

Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial.

Gheorghiade M, Böhm M, Greene SJ, Fonarow GC, Lewis EF, Zannad F, Solomon SD, Baschiera F, Botha J, Hua TA, Gimpelewicz CR, Jaumont X, Lesogor A, Maggioni AP; ASTRONAUT Investigators and Coordinators..

JAMA. 2013 Mar 20;309(11):1125-35. doi: 10.1001/jama.2013.1954. Erratum in: JAMA. 2013 Apr 10;309(14):1461.

PMID:
23478743
3.

Prevalence and characteristics of left ventricular noncompaction in a community hospital cohort of patients with systolic dysfunction.

Sandhu R, Finkelhor RS, Gunawardena DR, Bahler RC.

Echocardiography. 2008 Jan;25(1):8-12. doi: 10.1111/j.1540-8175.2007.00560.x.

PMID:
18186774
4.

Audit of stroke care at the Institute of Neurology, National Hospital of Sri Lanka, 1994-1997.

Ranawaka UK, Fernando MA, Gunasekera TG, Senanayake BS, Gunawardena DR, Wijesekera JC, Fernando DJ.

Ceylon Med J. 2002 Sep;47(3):86-8.

PMID:
12449773

Supplemental Content

Loading ...
Support Center